Insights - AbbVie (ABBV) is walking back its plan to buy Shire Plc (SHPG) on concerns over new U.S. laws making it harder for American companies to lower taxes through inversions, or … Continue Reading
Read NowInsights - Johnson & Johnson (JNJ) reported third quarter earnings on Tuesday and $18.5 billion in revenue (+5.1% over the quarter a year ago), with net earnings of $4.7 billion … Continue Reading
Read NowInsights - At a medical meeting this week Alnylam Pharmaceuticals (ALNY) reported six-month data from an ongoing study of patisiran (ALN-TTR02) in the rare disorder TTR-mediated amyloidosis (ATTR) in patients with … Continue Reading
Read NowInsights - Shares of Exact Sciences (EXAS) ripped higher on Friday with news that reimbursement for Cologuard should come in at the high end of analyst and investor … Continue Reading
Read NowInsights - Endo Health (ENDP) and Auxilium Pharmaceuticals (AUXL) finally came to terms in ongoing buyout negotiations, with ENDP handing over $2.6 billion ($33.25 per share) in … Continue Reading
Read NowResearch - Late-breaking abstracts from AASLD’s upcoming The Liver Meeting were published on Tuesday morning at 10:00 AM, and a number of companies with development-stage therapeutics in the space felt the impact. … Continue Reading
Read Now
